Insights

Innovative Product Pipeline DOR BioPharma specializes in developing advanced therapeutics for life-threatening gastrointestinal conditions and vaccines for bioterrorism agents, presenting opportunities to partner with organizations seeking cutting-edge biopharmaceutical solutions.

Late-Stage Development With its lead product orBec® in late-stage development, DOR is positioned to potentially enter the commercial market soon, offering sales prospects in both clinical and post-approval phases for specialized healthcare providers.

Healthcare Industry Focus Targeting critical and niche medical areas such as GI GVHD and serious gastrointestinal diseases, DOR presents opportunities to collaborate with hospitals, research institutions, and pharmaceutical companies looking to enhance their portfolio of life-saving treatments.

Growth & Funding Potential Although specific funding details are not provided, the company's revenue range indicates potential for strategic investments or partnerships aimed at accelerating product commercialization and scaling sales efforts.

Technology and Data Use Utilizing advanced technology stacks and strong infrastructure, DOR exhibits capabilities to support sophisticated data management and digital marketing strategies, which can be leveraged to reach targeted healthcare markets effectively.

DOR BioPharma, Inc. Tech Stack

DOR BioPharma, Inc. uses 8 technology products and services including RSS, Font Awesome, Google Fonts API, and more. Explore DOR BioPharma, Inc.'s tech stack below.

  • RSS
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Lua
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Apache
    Web Servers
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

DOR BioPharma, Inc.'s Email Address Formats

DOR BioPharma, Inc. uses at least 1 format(s):
DOR BioPharma, Inc. Email FormatsExamplePercentage
FLast@dorbiopharma.comJDoe@dorbiopharma.com
33%
LFirst@dorbiopharma.comDJohn@dorbiopharma.com
17%
FLast@dorbiopharma.comJDoe@dorbiopharma.com
33%
LFirst@dorbiopharma.comDJohn@dorbiopharma.com
17%

Frequently Asked Questions

Where is DOR BioPharma, Inc.'s headquarters located?

Minus sign iconPlus sign icon
DOR BioPharma, Inc.'s main headquarters is located at Princeton, New Jersey 08540 United States. The company has employees across 2 continents, including North AmericaEurope.

What is DOR BioPharma, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact DOR BioPharma, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DOR BioPharma, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
DOR BioPharma, Inc.'s official website is dorbiopharma.com and has social profiles on LinkedIn.

What is DOR BioPharma, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
DOR BioPharma, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does DOR BioPharma, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, DOR BioPharma, Inc. has approximately 31 employees across 2 continents, including North AmericaEurope. Key team members include Marketing Manager: A. O.. Explore DOR BioPharma, Inc.'s employee directory with LeadIQ.

What industry does DOR BioPharma, Inc. belong to?

Minus sign iconPlus sign icon
DOR BioPharma, Inc. operates in the Biotechnology Research industry.

What technology does DOR BioPharma, Inc. use?

Minus sign iconPlus sign icon
DOR BioPharma, Inc.'s tech stack includes RSSFont AwesomeGoogle Fonts APILuaX-Content-Type-OptionsApacheOpenRestyNginx.

What is DOR BioPharma, Inc.'s email format?

Minus sign iconPlus sign icon
DOR BioPharma, Inc.'s email format typically follows the pattern of FLast@dorbiopharma.com. Find more DOR BioPharma, Inc. email formats with LeadIQ.

DOR BioPharma, Inc.

Biotechnology ResearchNew Jersey, United States11-50 Employees

DOR BioPharma, Inc. ( DOR ) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR’s lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation.

Section iconCompany Overview

Headquarters
Princeton, New Jersey 08540 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    DOR BioPharma, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    DOR BioPharma, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.